Serotonin in Alcoholism
NCT00011752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2008-03-04
Summary
This study uses positron emission tomography (PET) scanning to study how serotonin works in alcoholics. Serotonin is a chemical that allows brain cells to communicate. There is evidence that people with alcoholism have altered serotonin; their brains begin to make and break down serotonin more slowly than people who do not drink. PET scans use radioactive substances injected into the body. A special camera detects the radiation emitted by the radioactive fluid and a computer processes the radioactivity into images of the brain, which show the activity of brain chemicals like serotonin.
People with alcohol dependency may participate in this study. Candidates are screened with a medical history, including questions about alcohol and drug use, physical examination, blood tests, breath alcohol tests, electrocardiogram (ECG), urine test for illicit drugs and, for women, a pregnancy test, and a stool test for hidden blood. They also undergo magnetic resonance imaging (MRI) scan of the brain and complete questionnaires on their alcohol and drug history.
Participants undergo the following tests and procedures:
* Diet low in tryptophan. Tryptophan is an amino acid from which serotonin is made.
* Brain MRI before starting the study to make sure brain structure is normal.
* Lumbar puncture (spinal tap) to collect a small sample of cerebrospinal fluid (CSF). A local anesthetic is given and a needle is inserted in the space between the bones (vertebrae) in the lower back. About 2 tablespoons of fluid is collected through the needle.
* Arterial catheter (plastic tube) placed in an artery in the wrist area for drawing blood samples. The skin is numbed with a local anesthetic for placement of the catheter.
* Intravenous (IV) catheter placed in a vein for injecting the radioactive isotope used in the PET scan.
* Two PET scans - baseline and active.
* Amino acid drink (orange flavored) before the active PET scan. The drink lowers tryptophan levels.
* Amino acid capsules - 23 amino acid capsules are taken with the orange drink.
* Genetic analysis to help understand serotonin and alcoholism. A blood sample is collected for DNA testing and possibly establishment of a cell line (collection of cells that are grown in the laboratory from an original tissue specimen) for other genetic studies.
Patients are admitted to the intensive care unit for the lumbar puncture and arterial line procedures. After these procedures are complete, the patient is transferred by stretcher to the PET suite for scanning. During the two scans, blood samples are drawn from the artery and a small amount of CSF is collected each hour of the study. Each PET scanning session lasts about 3 hours. The study lasts 36 hours, during which time the subject remains in bed.
Conditions
- Alcoholism
- Healthy
Interventions
- DRUG
-
FCWAY
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-02-28
- Completion
- 2005-09-30
Countries
- United States
Study Locations
More Related Trials
-
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
NCT01625611 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
NCT07027839 ·Status: RECRUITING ·Phase: PHASE1
-
[C-11]PiB PET Imaging in Alcohol Use Disorders
NCT03746366 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
NCT05957159 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
NCT00816439 ·Status: COMPLETED
-
Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder
NCT03829761 ·Status: COMPLETED ·Phase: NA
-
Brain Inflammation and Function in Alcoholism
NCT02233868 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PT150 Drug for Use in Alcohol Use Disorder
NCT06712602 ·Status: RECRUITING ·Phase: PHASE1
-
Neural Mechanisms of Disulfiram Effects
NCT02735577 ·Status: COMPLETED ·Phase: PHASE4
-
Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration
NCT04971681 ·Status: TERMINATED ·Phase: NA
-
Clinical Intervention in Alcohol Use Disorder
NCT02168400 ·Status: COMPLETED ·Phase: NA
-
Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study
NCT03152760 ·Status: COMPLETED
-
Neuroscience-Informed Treatment Development for Adolescent Alcohol Use
NCT03238300 ·Status: COMPLETED ·Phase: PHASE2
-
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717 ·Status: COMPLETED ·Phase: NA
-
Oxytocin and Stress Response in Alcohol Use Disorder
NCT03610633 ·Status: COMPLETED ·Phase: PHASE2
-
Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
NCT00449007 ·Status: TERMINATED ·Phase: PHASE4
-
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
NCT00612352 ·Status: COMPLETED ·Phase: NA
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse
NCT02616094 ·Status: COMPLETED ·Phase: NA
-
A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder
NCT03535129 ·Status: COMPLETED ·Phase: NA
-
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
NCT02842073 ·Status: COMPLETED ·Phase: PHASE2
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI
NCT02791945 ·Status: COMPLETED ·Phase: PHASE2